Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
StageZero Life Sciences's operating assets for the quarter that ended in Sep. 2024 was $0.57 Mil. StageZero Life Sciences's operating liabilities for the quarter that ended in Sep. 2024 was $9.57 Mil. StageZero Life Sciences's Total Assets for the quarter that ended in Jun. 2024 was $0.58 Mil. Therefore, StageZero Life Sciences's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was -15.42.
StageZero Life Sciences Scaled Net Operating Assets Related Terms
StageZero Life Sciences Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for StageZero Life Sciences's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
StageZero Life Sciences Scaled Net Operating Assets Chart
SZLSF vs IDTA, TTOO, NSTM: Scaled Net Operating Assets Comparison
For the Diagnostics & Research subindustry, StageZero Life Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
StageZero Life Sciences Scaled Net Operating Assets vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, StageZero Life Sciences's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where StageZero Life Sciences's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of -15.42 mean?
StageZero Life Sciences (SZLSF) has a Scaled Net Operating Assets of -15.42 as of Sep. 2024. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on StageZero Life Sciences and its competitors.
Is StageZero Life Sciences' Scaled Net Operating Assets too high?
StageZero Life Sciences' current Scaled Net Operating Assets is -15.42. Overall, StageZero Life Sciences has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does StageZero Life Sciences' Scaled Net Operating Assets compare to IDTA and TTOO?
StageZero Life Sciences' Scaled Net Operating Assets of -15.42 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Diagnostics & Research company?
A good Scaled Net Operating Assets depends on the Medical Diagnostics & Research industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on StageZero Life Sciences and its competitors. StageZero Life Sciences's current Scaled Net Operating Assets is -15.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is StageZero Life Sciences stock overvalued right now?
StageZero Life Sciences (SZLSF) has a current Scaled Net Operating Assets of -15.42. The current Scaled Net Operating Assets is -15.42. StageZero Life Sciences' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For StageZero Life Sciences (SZLSF), the current Scaled Net Operating Assets is -15.42 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
StageZero Life Sciences Ltd is a vertically integrated healthcare company at the nexus of three sectors of healthcare; Early Cancer Detection, Liquid Biopsy, and Global Telehealth. It is focused on minimizing the risk of cancer and other chronic diseases through early detection and intervention. It continues to develop and commercialize proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a focus on cancer-related indications. It has developed a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. The Company's lead product, Aristotle, is a blood-based molecular diagnostic assessment that can detect an individual's current risk for potentially having a variety of cancers.
10GF Score
Get the complete analysis for SZLSF
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZLSF has been successfully added to your 
